Found 35 matching trials
Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
PHASE2Purposes:
The purpose of this phase-II clinical trial is to determine whet...
Location
China Medical University Hospital
Neoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast Cancer
PHASE1RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Location
Eppley Cancer Center, University of Nebraska Medical Center
Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients.
PHASE2This phase II, randomized, open-label trial aims to assess whether the vacc...
Location
UO Immunoterapia e laboratorio TCS, IRST IRCCS
Dendritic Cell Cancer Vaccine for High-grade Glioma
PHASE2A randomised, open-label, 2-arm, multi-centre, phase II clinical study with...
Location
Landesnervenklinik Wagner-Jauregg
Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
PHASE1This treatment study for relapsed high-risk neuroblastoma, Ewings sarcoma, ...
Location
University of Louisville, Kosair Charities Pediatric Clinical Research Unit
Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
PHASE2Adult patients who have surgical resection of newly diagnosed glioblastoma ...
Location
Dartmouth-Hitchcock Medical Center
Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer
PHASE2This trial proposes to evaluate the immunologic and potential clinical effe...
Location
UMPC Hillman Cancer Center
Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.
PHASE2Single-arm, monocentric trial to assess safety and immunological efficacy o...
Location
UO Immunoterapia e Laboratorio TCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) S.r.l IRCCS
A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.
PHASE2Single-arm, monocentric trial to assess safety and immunological efficacy o...
Location
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)
Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
PHASE2RATIONALE: Biological therapies, such as interferon-gamma and aldesleukin, ...
Location
Multiple Locations